Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Peak Bio, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/18/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/15/2023 4 Huh Hoyoung (10% Owner) has filed a Form 4 on Peak Bio, Inc.
Txns: Exercised (in-or-at-the-money) 583,333 options to buy @ $0.6, valued at $350k
08/15/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Second Amendment to Common Stock Purchase Agreement, by and between Peak Bio, Inc. and White Lion Capital LLC"
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/11/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/03/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/24/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/21/2023 8-K Quarterly results
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 4 Huh Hoyoung (Director) has filed a Form 4 on Peak Bio, Inc.
Txns: Granted 1,884,625 options to buy @ $0.6, valued at $1.1M
Granted convertible notes @ $1130775, valued at $0
05/02/2023 4 Neal James R (Director) has filed a Form 4 on Peak Bio, Inc.
Txns: Granted 33,340 options to buy @ $0.6, valued at $20k
Granted convertible notes @ $20004, valued at $0
05/01/2023 8-K Quarterly results
04/21/2023 8-K Quarterly results
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/21/2023 SC 13D Huh Hoyoung reports a 40.2% stake in Peak Bio, Inc.
03/17/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/17/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Amendment to Common Stock Purchase Agreement, by and between Peak Bio, Inc. and White Lion Capital LLC",
"Amendment to Common Stock Purchase Agreement, by and between Peak Bio, Inc. and White Lion Capital LLC"
03/09/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Unsecured Promissory Notes, delivered by Peak Bio, Inc. to Hannol Ventures LLC",
"Unsecured Promissory Notes, delivered by Peak Bio, Inc. to Hannol Ventures LLC"
03/03/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/28/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/28/2023 3 SBI INVESTMENT KOREA CO., LTD. (10% Owner) has filed a Form 3 on Peak Bio, Inc.
02/14/2023 SC 13G/A Vellar Opportunities Fund Master, Ltd. reports a 0% stake in IGNYTE ACQUISITION CORP.
02/10/2023 SC 13G/A Flynn James E reports a 1.8% stake in Peak Bio, Inc.
02/03/2023 SC 13G/A FROST PHILLIP MD ET AL reports a 1.6% stake in §240.13d-2 PEAK BIO, INC.
01/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/09/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/04/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Form of PIPE Subscription Agreement, by and between Peak Bio, Inc. and the Investor party thereto",
"Form of Amendment to Lock-Up Agreement",
"Amendment to Key Company Stockholder Forward Purchase Agreement, by and between Peak Bio, Inc. and Hoyoung Huh",
"Unaudited pro forma condensed combined financial information of the Company and the related notes thereto as of and for the nine months ended September 30, 2022 and for the year ended December 31, 2021"
11/21/2022 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "8-K/A",
"Unaudited carve-out condensed consolidated financial statements of Peak Bio as of September 30, 2022 and December 31, 2021 and for the nine months ended September 30, 2022 and 2021",
"Unaudited pro forma condensed combined financial information of the Company and the related notes thereto as of and for the nine months ended September 30, 2022 and for the year ended December 31, 2021",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations of Peak Bio for the nine months ended September 30, 2022 and 2021"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy